Martin St. Jean
Career history of Martin St. Jean
Former positions of Martin St. Jean
Companies | Position | Start | End |
---|---|---|---|
Medicago, Inc.
Medicago, Inc. BiotechnologyHealth Technology Medicago, Inc. is a clinical-stage biopharmaceutical company. It develops novel vaccines and therapeutic proteins to address a broad range of infectious diseases worldwide. The firm provides vaccines and therapeutic proteins based on its proprietary Virus-Like Particles and manufacturing technologies. It develops Virus-Like Particles vaccines using a transient expression system which produces recombinant vaccine antigens in plants. The company was founded by Louis-Philippe Vézina on July 17, 1997 and is headquartered in Quebec, Canada. | Director/Board Member | - | - |
Société Générale de Financement du Québec
Société Générale de Financement du Québec Investment ManagersFinance A department of the province of Québec, the Société Générale de Financement du Québec (SGF) provides development capital for businesses. They are headquartered in Montreal with offices in Québec and Saint-Hyacinthe. The firm was founded in 1962. | Head-Equity Investments | 2004-03-03 | - |
Statistics
International
Canada | 3 |
Operational
Head-Equity Investments | 1 |
Director/Board Member | 1 |
Sectoral
Finance | 2 |
Health Technology | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Private companies | 2 |
---|---|
Société Générale de Financement du Québec
Société Générale de Financement du Québec Investment ManagersFinance A department of the province of Québec, the Société Générale de Financement du Québec (SGF) provides development capital for businesses. They are headquartered in Montreal with offices in Québec and Saint-Hyacinthe. The firm was founded in 1962. | Finance |
Medicago, Inc.
Medicago, Inc. BiotechnologyHealth Technology Medicago, Inc. is a clinical-stage biopharmaceutical company. It develops novel vaccines and therapeutic proteins to address a broad range of infectious diseases worldwide. The firm provides vaccines and therapeutic proteins based on its proprietary Virus-Like Particles and manufacturing technologies. It develops Virus-Like Particles vaccines using a transient expression system which produces recombinant vaccine antigens in plants. The company was founded by Louis-Philippe Vézina on July 17, 1997 and is headquartered in Quebec, Canada. | Health Technology |
- Stock Market
- Insiders
- Martin St. Jean
- Experience